Exploratory/Developmental Bioengineering Research Grants (EBRG)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant focuses on identifying cancer risks and strategies to reduce them, understanding factors that cause cancer, and developing methods for cancer prevention and interventions.
The overall goals of this NOFO are to identify cancer risks and risk reduction strategies, to identify factors that cause cancer in humans, and to discover and develop mechanisms for cancer prevention and preventive interventions in humans.
Source
Grant ID
PAR-25-346
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
December 11, 2024
Eligibility
The following categories of applicants are invited to apply:
- Public/State Controlled Institutions of Higher Education
- Private Institutions of Higher Education
- Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)
- For-Profit Organizations (Small Businesses)
- For-Profit Organizations (Other than Small Businesses)
- Local Governments (general)
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Indian/Native American Tribal Governments (Federally Recognized)
- Indian/Native American Tribal Governments (Other than Federally Recognized)
- Federal Government Agencies (Eligible Agencies of the Federal Government)
- U.S. Territories or Possessions
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Organizations (other than Federally recognized tribal governments)
- Faith-based or Community-based Organizations
- Regional Organizations
- Foreign Organizations (Non-domestic entities)
- Non-domestic (non-U.S.) components of U.S. Organizations
Additional Eligibility Information
- Foreign/non-U.S. entities are eligible. Non-domestic components of U.S. organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed in applications.
- Required registrations (must be completed prior to submission; can take 6+ weeks; failure to register on time is not a valid reason for late submission):
• System for Award Management (SAM) – active registration required; renew at least annually (domestic orgs receive/maintain CAGE code)…
Similar opportunities
- Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
- Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Prevention
- Forecast to Publish a Funding Opportunity Announcement for Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
- Exploratory/Developmental Research Grant Program (R21)
- National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)